iRhythm Technologies, Inc.

Equities

IRTC

US4500561067

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 21:00:00 12/09/2024 BST 5-day change 1st Jan Change
74.76 USD -0.09% Intraday chart for iRhythm Technologies, Inc. +14.64% -30.16%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
IRhythm Technologies Secures Japanese Approval for EGC Monitoring Device MT
Transcript : IRhythm Technologies, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 03:20 PM
IRhythm Technologies Signs License Agreement With BioIntelliSense for Multiparameter Sensor Technology MT
IRhythm Technologies, Inc. Reaffirms Earnings Guidance for the Year 2024 CI
IRhythm Technologies, Inc. Announces Results of GUARD-AF Trial CI
IRhythm Technologies Commercially Rolls out Zio Monitor, Zio LTCM ECG Service in Four European Countries MT
Needham Adjusts iRhythm Technologies' PT to $119 From $138, Keeps Buy Rating MT
Truist Adjusts iRhythm Technologies' PT to $117 From $134, Keeps Buy Rating MT
Oppenheimer Adjusts iRhythm Technologies Price Target to $145 From $165, Maintains Outperform Rating MT
IRhythm Technologies Appoints Daniel Wilson as Finance Chief MT
IRhythm Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
Earnings Flash (IRTC) IRHYTHM Reports Q2 Revenue $148M, vs. Street Est of $146.2M MT
Earnings Flash (IRTC) IRHYTHM Posts Q2 Loss $-0.61, vs. Street Est of $-0.88 MT
Transcript : IRhythm Technologies, Inc., Q2 2024 Earnings Call, Aug 01, 2024
IRhythm Technologies, Inc. Appoints Daniel Wilson as Principal Financial Officer, Effective as of August 31, 2024 CI
IRhythm Technologies, Inc. Announces Chief Financial Officer Transition, Effective August 31, 2024 CI
Irhythm Technologies, Inc. Provides Earnings Guidance for the Year 2024 CI
Truist Lowers Price Target on iRhythm Technologies to $134 From $145, Maintains Buy Rating MT
Morgan Stanley Cuts Price Target on iRhythm Technologies to $130 From $135, Keeps Overweight Rating MT
IRhythm Technologies Shares Rise After Upgrade From Wolfe Research MT
Wolfe Research Upgrades iRhythm Technologies to Outperform From Peer Perform, Price Target is $115 MT
IRhythm Technologies, Inc. Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation CI
Transcript : IRhythm Technologies, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 11:20 AM
Needham Adjusts iRhythm Technologies' PT to $138 From $137, Says 'Strong' Q1 Revenue Growth Should Continue; Keeps Buy Rating MT
Transcript : IRhythm Technologies, Inc., Q1 2024 Earnings Call, May 02, 2024
Chart iRhythm Technologies, Inc.
More charts
Logo iRhythm Technologies, Inc.
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
Employees
2,000
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
74.76USD
Average target price
117.55USD
Spread / Average Target
+57.23%
Consensus
  1. Stock Market
  2. Equities
  3. IRTC Stock
  4. News iRhythm Technologies, Inc.
  5. Earnings Flash (IRTC) IRHYTHM Posts Q2 Loss $-0.61, vs. Street Est of $-0.88
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW